Mark Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40,370	Closed	-$1.8M	–	51
2021 Q4	$1.8M	Buy	40,370 +19,841	+97%	+$940K	0.26%	44
2021 Q3	$1.04M	Sell	20,529 -18,310	-47%	-$1.03M	0.16%	48
2021 Q2	$3.05M	Sell	38,839 -73,080	-65%	-$4.52M	0.45%	40
2021 Q1	$6.39M	Sell	111,919 -60,121	-35%	-$4.02M	1.01%	31
2020 Q4	$14.4M	Sell	172,040 -7,389	-4%	-$447K	2.34%	19
2020 Q3	$6.43M	Sell	179,429 -1,069	-0.6%	-$32.2K	1.29%	34
2020 Q2	$4.36M	Buy	180,498 +17,976	+11%	+$423K	1.06%	37
2020 Q1	$2.85M	Buy	162,522 +95,965	+144%	+$2M	0.93%	37
2019 Q4	$1.16M	Sell	66,557 -2,307	-3%	-$38.4K	0.35%	49
2019 Q3	$1.05M	Sell	68,864 -1,668	-2%	-$31.9K	0.35%	45
2019 Q2	$1.46M	Hold	70,532	–	–	0.45%	44
2019 Q1	$1.64M	Buy	70,532 +50,632	+254%	+$1.06M	0.49%	44
2018 Q4	$411K	Buy	+19,900	New	+$361K	0.14%	52